RecruitingDiabetes MellitusNeuropathyNeuropathic Pain
Diabetic Neuropathy in Spinal Cord Stimulator Patients
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of this study is to assess the effect Spinal Cord Stimulators have toward improving vascular changes of diabetes mellitus in patients eligible for SCS placement based on their condition of painful diabetic neuropathy; we will evaluate improving their disability and quality of life, improving micro-circulatory changes induced by Diabetes Mellitus (DM), improving macro-circulatory changes induced by DM and improving arterial stiffness of the vessels of the lower extremity.
Sponsor: University of Chicago
You may qualify if…
- ✓ 1. Patients with DM type 2 of more than 1-year duration
- ✓ 2. DM stage 3 or less
- ✓ 3. Patients ≥18 years of age
- ✓ 4. Refractory painful diabetic peripheral neuropathy of the lower extremities
- ✓ 5. ABI index \<0.9
You may not qualify if…
- ✕ 1. Patients on anticoagulants
- ✕ 2. Patients with active infections
- ✕ 3. Patients with HbA1\>10
- ✕ 4. Psychiatric disorders and cognitive dysfunctions
- ✕ 5. Illicit Drug Usage
- ✕ 6. Patients on dialysis
- ✕ 7. BMI\>35.0
- ✕ 8. Surgery within the last 30 days
Where it's recruiting
Illinois
Chicago
Source: ClinicalTrials.gov · NCT04687215 · last updated 2026-02-05